Literature DB >> 11298544

Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study.

Y J Chen1, C Y Wu, J L Shen.   

Abstract

BACKGROUND: An association between dermatomyositis (DM)/polymyositis (PM) and malignancies has been widely reported in the literature. The validity of extensive evaluation for malignancies in those patients has also been questioned for decades. Only limited papers regarding the signs of malignancy and the prognostic factors in DM/PM have been reported.
OBJECTIVES: To define the potential risk factors of concomitant neoplastic diseases in patients diagnosed as having DM/PM.
METHODS: From 1 April 1983 to 30 June 1999, 147 patients were diagnosed as having probable or definite DM/PM at the Veterans General Hospital, Taichung, Taiwan. We excluded four patients who had preceding neoplastic diseases diagnosed before DM/PM, then retrospectively reviewed the data of the remaining 143 patients and subgrouped the cases as four main types: primary idiopathic DM, primary idiopathic PM, juvenile DM/PM and amyopathic DM (ADM). We next performed univariate analysis using logistic regression to evaluate the possible predictive factors for malignancies, such as mean age at onset, gender, manifestations at onset, association with other connective tissue diseases, initial skin presentations, complications and laboratory data. Then we chose the significant factors for multivariate analysis by logistic regression, to determine the independent risk factors of malignancies in DM/PM patients.
RESULTS: Among the 143 patients, DM was the most common type (64%), followed by ADM (14%), juvenile DM/PM (13%) and PM (10%). The mean age at onset overall was 42.4 years. Other connective tissue diseases were present in 22% of all patients, especially PM (50%) and juvenile DM/PM patients (28%). Internal malignancies were present in 13% of patients, and most were associated with DM. Nasopharyngeal carcinomas (NPCs) were the most common tumours. Patients with primary idiopathic DM, with an older age at onset, higher serum creatine phosphokinase levels and male gender, had more chance of developing concomitant malignancies. Those associated with complications, especially interstitial lung diseases, had a lower risk of associated neoplasia. In multivariate analysis, an older age at onset (odds ratio 9.10) and male gender (odds ratio 4.06) were associated with greater risk of developing malignancies.
CONCLUSIONS: The two independent predictive factors for malignancy (P < 0.05) in patients with DM/PM were an older age at onset (> 45 years) and male gender. The primary idiopathic DM group was shown to have higher risk of developing internal malignancies, especially NPC. However, this was not identified as an independent predictive factor for concomitant neoplastic diseases in multivariate analysis. In addition, patients who had the complication of interstitial lung disease had a significantly lower frequency of malignancies (P < 0.001).

Entities:  

Mesh:

Year:  2001        PMID: 11298544     DOI: 10.1046/j.1365-2133.2001.04140.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  38 in total

Review 1.  Prognosis of polymyositis and dermatomyositis.

Authors:  A C F Hui; S M Wong; T Leung
Journal:  Clin Rheumatol       Date:  2006-07-06       Impact factor: 2.980

2.  Dermatomyositis associated with thyroid cancer: a paraneoplastic syndrome?

Authors:  Takao Nagashima; Sachiko Onishi; Yasuyuki Kamata; Seiji Minota
Journal:  Rheumatol Int       Date:  2009-01-14       Impact factor: 2.631

Review 3.  Myositis-related interstitial lung disease and antisynthetase syndrome.

Authors:  Joshua Solomon; Jeffrey J Swigris; Kevin K Brown
Journal:  J Bras Pneumol       Date:  2011 Jan-Feb       Impact factor: 2.624

4.  Cancer-associated myositis associated with oesophageal adenocarcinoma arising in Barrett's oesophagus without serum myogenic enzymes elevation: an example suggesting the importance of MRI.

Authors:  Yosuke Sasaki; Hiroshige Shimizu; Tetsuo Nemoto; Yoshihisa Urita
Journal:  BMJ Case Rep       Date:  2016-04-21

Review 5.  Amyopathic dermatomyositis: definitions, diagnosis, and management.

Authors:  Elizabeth E Bailey; David F Fiorentino
Journal:  Curr Rheumatol Rep       Date:  2014-12       Impact factor: 4.592

6.  A case of erythrodermic dermatomyositis associated with gastric cancer.

Authors:  Sung Woo Kim; Yoo Seok Kang; Sang Hoon Park; Un Ha Lee; Hyun Su Park; Sang Jai Jang
Journal:  Ann Dermatol       Date:  2009-11-30       Impact factor: 1.444

7.  Cancer-associated myositis: a 35-year retrospective study of a monocentric cohort.

Authors:  Rossella Neri; Simone Barsotti; Barsotti Simone; Valentina Iacopetti; Giacomo Iacopetti; Pasquale Pepe; Anna d'Ascanio; Antonio Gaetano Tavoni; Marta Mosca; Stefano Bombardieri
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

8.  Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis.

Authors:  Hua Cao; Tanvi N Parikh; Jie Zheng
Journal:  Clin Rheumatol       Date:  2009-03-18       Impact factor: 2.980

9.  Malignancies in Korean patients with inflammatory myopathy.

Authors:  Sang-Won Lee; Sang Youn Jung; Min-Chan Park; Yong-Beom Park; Soo-Kon Lee
Journal:  Yonsei Med J       Date:  2006-08-31       Impact factor: 2.759

10.  Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan.

Authors:  Yi-Ju Chen; Chun-Ying Wu; Yu-Lin Huang; Chang-Bi Wang; Jui-Lung Shen; Yun-Ting Chang
Journal:  Arthritis Res Ther       Date:  2010-04-16       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.